Clinical Trials Directory

Trials / Completed

CompletedNCT00718744

Standardization of Chortoglyphus Arcuatus Allergenic Extract. Determination of Biological Activity in HEP Units

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Laboratorios Leti, S.L. · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Not accepted

Summary

The main purpose of the trial is to prove the therapeutic value of the product and enable an effective and safe dosage schedule to be recommended

Detailed description

The skin testing procedure, based on the Nordic Guidelines is the reference method for the biological calibration of in-House Reference Preparations (IHRP). The method is not intended for routine testing of allergen extracts. The use of this procedure is the basis for the definition of biological activity units: "the activity of an allergen extract is 10,000 Biological Units (BU) per ml (10 HEP per ml), when the extract provokes an specific skin reaction in the median sensitive patient with a wheal of the same size as a wheal provoked by a positive reference solution consisting of histamine 54.3 mmol/l (for example histamine dihydrochloride 10 mg/ml), when both solutions are administrated using the same technique (prick testing) on at least 20 individuals who are clinically allergic and cutaneously reactive to the allergen concerned".

Conditions

Interventions

TypeNameDescription
OTHERStandardization of allergenic extract (Ch. arcuatus)Allergenic extract for cutaneous prick-test

Timeline

Start date
2008-06-01
Primary completion
2008-11-01
Completion
2008-11-01
First posted
2008-07-21
Last updated
2010-08-05

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT00718744. Inclusion in this directory is not an endorsement.